Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed the clinical characteristics and treatment responses in patients who developed alopecia areata after COVID-19 infection or vaccination, highlighting the need for further research into the underlying pathogenesis and association.

This study reported that olive oil applications on the scalp may regenerate hair loss linked to SARS CoV-2 infection and vaccination, based on observations in two individuals.

This study observed that COVID-19 patients in Thailand infected with the Delta variant were more likely to develop pneumonia and certain post-infection conditions, while Omicron infections were associated with milder symptoms like sore throat and congestion.

This study reported an increased likelihood of hidradenitis suppurativa flares in patients who received mRNA COVID-19 vaccines compared to those who received non-mRNA vaccines, indicating a potential association that warrants further research in larger populations.

This study found that transfollicular delivery using surfactant-based nanoparticles significantly enhanced antigen stability and immune response compared to other delivery methods, especially when combined with an adjuvant.

A benign tumor developed at a girl's BCG vaccination site, not previously linked to the vaccine.

This review discusses vaccine safety concerns for individuals with autoimmune and inflammatory conditions, noting vaccine hesitancy due to observed exacerbations post-vaccination and a lack of comprehensive trial data.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

This study found that COVID-19 vaccines were generally well-tolerated among Bangladeshi medical students, with most side effects being mild and decreasing in frequency after subsequent doses.

This study found that COVID-19 vaccination initially lowered vitamin D levels in serum and hair but increased serum levels after the second dose, except for the Pfizer group. Hair vitamin D showed a nonsignificant increase, and hair loss was most common with the AstraZeneca vaccine.

This study concluded that the anti-SARS-CoV-2 vaccine does not significantly increase the risk of flares in patients with hidradenitis suppurativa.

The authors concluded that there is no increased association between COVID-19 vaccination and alopecia areata, and the overall incidence of the condition in vaccinated individuals matches historical controls.

This case report describes a woman who experienced worsened breast implant illness symptoms following a COVID-19 infection and vaccination, which improved after implant removal, even though numerous screenings had been inconclusive prior to explantation.

This article discusses the potential link between COVID-19 vaccines and hair loss, but presents no definitive clinical findings on this relationship.

This study reports that comorbidities and anti-androgen therapy were associated with lower SARS-CoV-2 vaccination rates among patients with androgenetic alopecia, emphasizing the need to promote vaccination within this group.

This commentary reports the first case of small fiber neuropathy, mast cell activation syndrome, and pericarditis following mRNA-based SARS-CoV-2 vaccination in a previously healthy 66-year-old woman.

This study observed a high prevalence of hair loss among adults after receiving COVID-19 vaccination, with two-thirds of participants experiencing this issue and a minority of cases possibly vaccine-related.

This report observed a case of pilomatrixoma appearing at the COVID-19 vaccination site of a 65-year-old man, aligning with previous findings that suggest a potential association between vaccination sites and this benign tumor.

In this study, patient-reported flare symptoms after COVID-19 vaccination in individuals with systemic lupus erythematosus were generally mild, with 17% experiencing flares mostly characterized by joint pain and fatigue; vaccine type did not affect flare incidence.

This report describes a case where a woman's hair loss following COVID-19 vaccination improved after treatment with autologous CD34+ hematopoietic progenitor cells and umbilical cord blood-derived mesenchymal stem cells, with no significant adverse effects observed over the 12-week treatment period.

In this observational study, researchers reported a significant association between COVID-19 infection or vaccination and the development of new-onset lichen planus, suggesting these events, particularly infection, may act as triggers for the condition.

This review discusses the development and rapid approval of COVID-19 vaccines and notes the observation of autoimmune disorders, such as alopecia areata, following vaccination; it provides no new clinical results.

This study identified a novel pathogenic splice-site variant of the LAMB3 gene in patients with junctional epidermolysis bullosa, highlighting the importance of gene sequencing for diagnosis.

This case report describes two cases of systemic lupus erythematosus (SLE) onset occurring within two months after COVID-19 vaccination, but it remains unclear if the vaccination contributed to these cases.

This study reports that a patient with subacute cutaneous lupus erythematosus experienced disease exacerbation after the first dose of the BNT162b2 mRNA COVID-19 vaccine, but tolerated the second dose without adverse reactions.

This article highlights the importance of recognizing, preventing, and reporting adverse drug reactions to the FDA's MedWatch program, but it presents no new research findings.

In this report, the authors describe a case where a child developed alopecia areata after receiving the fifth dose of a rabies vaccine, suggesting that the vaccine may predispose to this autoimmune hair loss by affecting immune regulation.

In this study, Korean patients with systemic lupus erythematosus reported worse perceptions and higher adverse events with the COVID-19 vaccine compared to the influenza vaccine.

This study found that psoriasis patients on biologic therapy had significantly lower anti-COVID19 IgG antibody levels after vaccination compared to healthy individuals not on biologic treatment.

This study described cases of alopecia areata occurring after COVID-19 vaccination and highlights management using both topical and systemic therapies.